More aggressive treatment doesn't impact quality of life for metastatic colorectal cancer patients, says new study

by National Comprehensive Cancer NetworkCredit: Unsplash/CC0 Public DomainNewresearchin the October 2023 issue ofJournal of the National Comprehensive Cancer Networkfinds that

Updated on: May 21,2024 3

More aggressive treatment doesn't impact quality of life for metastatic colorectal cancer patients, says new study

by National Comprehensive Cancer NetworkCredit: Unsplash/CC0 Public DomainNewresearchin the October 2023 issue ofJournal of the National Comprehensive Cancer Networkfinds that

Updated on:May 21,2024 3

Polybrominated diphenyl ether linked to increased risk for cancer mortality

by Elana GotkinePolybrominated diphenyl ether (PBDE) exposure is associated with an increased risk for cancer mortality, according to a studypublishedinJAMA Network Open.Buyun Liu, M

Updated on: April 06,2024 0

Polybrominated diphenyl ether linked to increased risk for cancer mortality

by Elana GotkinePolybrominated diphenyl ether (PBDE) exposure is associated with an increased risk for cancer mortality, according to a studypublishedinJAMA Network Open.Buyun Liu, M

Updated on:April 06,2024 0

Adcetris FDA approval expanded to include later-stage Hodgkin's

(HealthDay)—U.S. Food and Drug Administration approval of Adcetris (brentuximab vedotin) has been expanded to include adults with untreated stage III or IV classical Hodgkin's lymphoma, the agency

Updated on: March 30,2024 19

Adcetris FDA approval expanded to include later-stage Hodgkin's

(HealthDay)—U.S. Food and Drug Administration approval of Adcetris (brentuximab vedotin) has been expanded to include adults with untreated stage III or IV classical Hodgkin's lymphoma, the agency

Updated on:March 30,2024 19

Preclinical study shows promise of systemic targeted therapy in a rare form of cancer

byVall d'Hebron Institute of OncologyTreatment with BRAF inhibitors reduces tumor cell proliferation in subcutaneous BRAFV600EPMP-PDX tumors without impacting in apoptosis. a–d) Mice b

Updated on: August 03,2024 0

Preclinical study shows promise of systemic targeted therapy in a rare form of cancer

byVall d'Hebron Institute of OncologyTreatment with BRAF inhibitors reduces tumor cell proliferation in subcutaneous BRAFV600EPMP-PDX tumors without impacting in apoptosis. a–d) Mice b

Updated on:August 03,2024 0

Vaginal cancer incidence increasing globally

by Lori SolomonThe incidence of vaginal cancer is increasing globally, according to a studypublishedonline June 25 inBJOG: An International Journal of Obstetrics and Gynaecology.Junj

Updated on: July 05,2024 0

Vaginal cancer incidence increasing globally

by Lori SolomonThe incidence of vaginal cancer is increasing globally, according to a studypublishedonline June 25 inBJOG: An International Journal of Obstetrics and Gynaecology.Junj

Updated on:July 05,2024 0

Researchers complete largest genomic analysis of Merkel cell carcinoma patients

by H. Lee Moffitt Cancer Center & Research InstituteCredit: CC0 Public DomainMerkel cell carcinoma (MCC) is a rare, aggressive skin tumor that is diagnosed in approximately 2,000 people each

Updated on: June 04,2024 7

Researchers complete largest genomic analysis of Merkel cell carcinoma patients

by H. Lee Moffitt Cancer Center & Research InstituteCredit: CC0 Public DomainMerkel cell carcinoma (MCC) is a rare, aggressive skin tumor that is diagnosed in approximately 2,000 people each

Updated on:June 04,2024 7

Opinion: The urgent need to secure the future of the 'post-pandemic child'

by Monash UniversityCredit: Unsplash/CC0 Public DomainIn 2028, it will be eight years since COVID-19 was first detected in Australia. Today's post-pandemic child will be a teenager, facing a

Updated on: May 11,2024 6

Opinion: The urgent need to secure the future of the 'post-pandemic child'

by Monash UniversityCredit: Unsplash/CC0 Public DomainIn 2028, it will be eight years since COVID-19 was first detected in Australia. Today's post-pandemic child will be a teenager, facing a

Updated on:May 11,2024 6

Allogeneic stem cell transplantation in non-Hodgkin lymphoma: Benefit remains unclear

by Institute for Quality and Efficiency in Health CareCancer cell during cell division. Credit: National Institutes of HealthThe German Institute for Quality and Efficiency in Health Care (IQWiG)

Updated on: May 11,2024 8

Allogeneic stem cell transplantation in non-Hodgkin lymphoma: Benefit remains unclear

by Institute for Quality and Efficiency in Health CareCancer cell during cell division. Credit: National Institutes of HealthThe German Institute for Quality and Efficiency in Health Care (IQWiG)

Updated on:May 11,2024 8

Researchers identify enzyme that suppresses immune system in breast cancer

by Duke University Medical CenterThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by T

Updated on: June 04,2024 8

Researchers identify enzyme that suppresses immune system in breast cancer

by Duke University Medical CenterThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by T

Updated on:June 04,2024 8

Researchers discover possible way to make resistant melanomas susceptible to immunotherapy

by Ludwig Institute for Cancer ResearchMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0A Ludwig Cancer Research st

Updated on: June 22,2024 8

Researchers discover possible way to make resistant melanomas susceptible to immunotherapy

by Ludwig Institute for Cancer ResearchMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0A Ludwig Cancer Research st

Updated on:June 22,2024 8

Researchers define mechanism that causes kidney cancer to recur

by University of Texas Health Science Center at San AntonioNew research from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and U.S. Department of Veterans A

Updated on: June 08,2024 5

Researchers define mechanism that causes kidney cancer to recur

by University of Texas Health Science Center at San AntonioNew research from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and U.S. Department of Veterans A

Updated on:June 08,2024 5

Investigators build a better targeted drug therapy using the power of computation

by Brigham and Women's HospitalCancer cell during cell division. Credit: National Institutes of HealthAntibody drug conjugates (ADCs)—cancer drugs that are designed to target and destroy canc

Updated on: June 08,2024 5

Investigators build a better targeted drug therapy using the power of computation

by Brigham and Women's HospitalCancer cell during cell division. Credit: National Institutes of HealthAntibody drug conjugates (ADCs)—cancer drugs that are designed to target and destroy canc

Updated on:June 08,2024 5